Cerivastatin and gemfibrozil-induced cardiac rhabdomyolysis.
Mark
M
Su
Robert S
RS
Hoffman
Mark
M
Flomenbaum
D009202:Cardiomyopathies / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D015248:Gemfibrozil / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; C086276:cerivastatin; D015248:Gemfibrozil